Reduced Craniospinal Radiation Therapy and Chemotherapy in Treating Younger Patients With Newly Diagnosed WNT-Driven Medulloblastoma

NCT02724579 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

45

Enrollment

NETWORK

Sponsor class

Conditions

Medulloblastoma

Interventions

DRUG: Cisplatin
DRUG: Cyclophosphamide
OTHER: Laboratory Biomarker Analysis
DRUG: Lomustine
PROCEDURE: Magnetic Resonance Imaging
RADIATION: Radiation Therapy
DRUG: Vincristine
DRUG: Vincristine Sulfate

Sponsor

Children's Oncology Group

Collaborators

[object Object]